Status:
COMPLETED
Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study
Lead Sponsor:
Thomas Jefferson University
Conditions:
Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This trial tests new methods and materials for the real-time chemotherapy-associated side effects monitoring support system (RT-CAMSS) in patients with gastrointestinal cancers undergoing chemotherapy...
Detailed Description
PRIMARY OBJECTIVES: I. Develop and refine a real-time chemo-associated side effects monitoring support system (RT-CAMSS) using interactive text messaging (TXT) for patients with gastric, esophageal, ...
Eligibility Criteria
Inclusion
- Patients diagnosed with gastric, esophageal, pancreatic or colorectal cancer
- Scheduled to start intravenous (IV) chemotherapy or has started IV chemotherapy
- Able to read and understand English
- Able to provide signed and dated informed consent form
- Have a mobile device with text message capability
- Know or willing to learn how to use text messaging
Exclusion
- \< 18 years of age
- Cognitive impairment documented in the electronic medical record (EMR), biological variables (sex)
Key Trial Info
Start Date :
April 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 24 2022
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04449679
Start Date
April 15 2020
End Date
February 24 2022
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States, 19107